Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

A woman reported losing sight in her left eye just a day after receiving her first semaglutide injection for diabetes ... definitive evidence linking the drug to blindness, doctors advised ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo.

(Off-label use is when doctors prescribe a drug for a purpose other than ... current by reading our editorial policy. Ozempic (semaglutide) injection, for subcutaneous use. (2025).

The topline results from the ESSENCE trial of semaglutide showed that a once-weekly 2.4mg dose of the drug was better than placebo at resolving MASH and improving liver fibrosis, meeting its ...

Coupons and drug savings programs can also lower the price you’ll pay for Rybelsus. As with all medications, the cost of Rybelsus can vary. Factors that may affect the price you’ll pay include ...